To this end, we analyzed published GEP data (GEO: GSE106819)28 which utilized the mTOR inhibitor, everolimus, to characterize the differential gene expression changes that occur due to mTOR signaling in ccRCC cell lines. This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.